European Commission Grants Funds to Reduce Antibiotic Misuse
Commission funding will be used to validate the clinical utility and cost-effectiveness of the ImmunoXpert, a diagnostic test that distinguishes bacterial from viral infections.
Read More
Search Results for: infectious diseases
BioLytical Laboratories Announces US Patent Filings for Zika Detection Assays
The patent applications expand the company’s growing intellectual property portfolio, and include an immunoassay system for the detection of antibodies to such pathogens as Zika and other flaviviruses.
Read More
Taking Aim at Sepsis
New guidelines and advanced tests have enabled earlier diagnosis and improved patient outcomes.
Read More
FDA Continues EUA Allowances for Zika Diagnostics
A molecular diagnostic from Luminex is the latest to receive emergency use authorization to detect Zika virus.
Read More
AACC 2016 Roundup
Here’s an overview of news that CLP highlighted in its AACC 2016 blog.
Read More